Dr. Reddy’s will manufacture the Active Pharmaceutical Ingredient and finished drug at its facilities approved by USFDA
Purchase agreement with ViewRay will make state-of-the art precision radiation therapy available in China
Acquisitions have the potential to add at least $1 billion in sales by 2028
Ipca Laboratories now holds 58.88% of the paid-up equity share capital of the company.
Shandong Meditech Medical Technology is a manufacturer of onsite oxygen solutions for the healthcare market.
The acquired brands are well established and recognized among doctors and other members of the medical fraternity in Brazil for their reliability, safety, and trustworthiness
Oncodesign Services (ODS ), with 600 clients in 33 countries and 227 employees worldwide, provides services from target identification to hit-to-lead and lead optimization through to IND filing.
DKSH has signed an agreement to acquire two ear care brands from Noru Pharma for Australia, New Zealand, and selected markets in Asia.
Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community
This acquisition will accelerate Medcare's plans to emerge as an international hub for health, beauty, and wellness adding to its existing network of 4 hospitals and over 20 medical centres in the UAE.
Subscribe To Our Newsletter & Stay Updated
